ロード中...
Translesion synthesis DNA polymerases η, ι, and ν promote mutagenic replication through the anticancer nucleoside cytarabine
Cytarabine (AraC) is the mainstay for the treatment of acute myeloid leukemia. Although complete remission is observed in a large proportion of patients, relapse occurs in almost all the cases. The chemotherapeutic action of AraC derives from its ability to inhibit DNA synthesis by the replicative p...
保存先:
| 出版年: | J Biol Chem |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Biochemistry and Molecular Biology
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6916505/ https://ncbi.nlm.nih.gov/pubmed/31685662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.RA119.011381 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|